XOMA: the balance sheet

MyFinsight

For the year ending 2025-12-31, XOMA has $272,698K in assets. $168,738K in debts. $82,908K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
336.76%
Quick Ratio
336.76%
Cash Ratio
238.10%
Debt to Asset Ratio
61.88%
Unit: Thousand (K) dollars
Assets Breakdown
Cash and cash equivalents
Long-term royalty and commercial...
Long-term restricted cash
Others
Liabilities Breakdown
Additional paid-in capital
Accumulated deficit
Long-term operating lease liabil...
Others

Balance Sheets	2025-12-31
Cash and cash equivalents	82,908
Short-term restricted cash	5,441
Investment in equity securities	382
Trade and other receivables, net	4,896
Short-term royalty and commercial payment receivables under the eir method	22,780
Prepaid expenses and other current assets	852
Total current assets	117,259
Long-term restricted cash	45,361
Property and equipment, net	21
Operating lease right-of-use assets	256
Long-term royalty and commercial payment receivables under the eir method	4,433
Long-term royalty and commercial payment receivables under the cost recovery method	55,888
Exarafenib milestone asset (note 6)	3,600
Investment in warrants	697
Intangible assets, net	44,756
Other assets - long term	427
Total assets	272,698

Accounts payable	2,208
Accrued and other current liabilities	9,885
Operating lease liabilities	2,464
Unearned revenue recognized under units-of-revenue method	1,268
Preferred stock dividend accrual	1,424
Current portion of long-term debt	12,526
Contingent value rights liabilities - current portion	5,045
Total current liabilities	34,820
Unearned revenue recognized under units-of-revenue method - long-term	3,193
Exarafenib milestone contingent consideration (note 6)	3,600
Long-term operating lease liabilities	20,114
Long-term debt	96,451
Contingent value rights liabilities - long-term	10,457
Deferred tax liability	103
Total liabilities	168,738
Convertible preferred stock, 0.05 par value, 5,003 shares authorized, issued and outstanding as of december 31, 2025 and december 31, 2024	20,019
Preferred stock	49
Common stock, 0.0075 par value, 277,333,332 shares authorized, 11,858,955 and 11,952,377 shares issued and outstanding as of december 31, 2025 and december 31, 2024, respectively	89
Additional paid-in capital	1,305,200
Accumulated other comprehensive income	53
Accumulated deficit	-1,221,450
Total stockholders' equity	83,941
Total liabilities, convertible preferred stock and stockholders' equity	272,698

Unit: Thousand (K) dollars (except for numbers of shares and EPS).

MyFinsight

Balance Sheets Overview

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Balance Sheets Overview

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets